A contextual framework is built that specifies when HO-1 activation is protective versus detrimental, organised around three converging determinants: cell-type specificity, iron-handling capacity, and disease stage, which is extended to the often-overlooked dimensions of sex, age, and model heterogeneity, and used to interrogate conflicting findings across the literature.
Abstract
Neurological disorders, including ischaemic and haemorrhagic stroke, traumatic brain injury, and chronic neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis, represent a major global health burden. Despite diverse etiologies, these conditions share common pathological mechanisms driven by oxidative stress, neuroinflammation, mitochondrial dysfunction, iron dysregulation, and secondary neuronal injury. The nuclear factor erythroid 2-related factor 2 (Nrf2) signalling cascade and its downstream target heme oxygenase-1 (HO-1) are master regulators of cellular redox homeostasis. HO-1 plays a pivotal yet dichotomous role: its products biliverdin/bilirubin and carbon monoxide exert antioxidant, anti-inflammatory, and anti-apoptotic effects, whereas excessive HO-1 induction can exacerbate iron-mediated oxidative injury and ferroptosis through the release of redox-active ferrous iron. Rather than cataloguing protective studies, this review builds a contextual framework that specifies when HO-1 activation is protective versus detrimental, organised around three converging determinants: cell-type specificity, iron-handling capacity, and disease stage. We extend this framework to the often-overlooked dimensions of sex, age, and model heterogeneity, and use it to interrogate conflicting findings across the literature. We further dissect how Nrf2/HO-1 regulates ferroptosis through the GPX4-ACSL4-SLC7A11 axis, critically appraise the largely unexamined relationship between Nrf2 and the parallel FSP1/CoQ10, GCH1/BH4, and DHODH defence systems, and distil lessons from clinical trials of Nrf2 activators. The goal is an analytical account that identifies where the evidence is robust, where it is contradictory, and where the principal research gaps lie.
Understanding the mechanism of these players gives a mechanistic framework for the development of targeted therapeutic and nutritional interventions to reduce neuronal damage and help slow the progression of CNS disorders.
Khuzin Dinislam, V. A. Kataev, Mohammad Rehan Ajmal et al.· Frontiers in Aging Neuroscie...· 0 citations
Current evidence on the molecular mechanisms linking miRNAs and ferroptosis in SCI is summarized, highlighting how miRNA-mediated regulation of ferroptosis contributes to neuronal death, glial responses, and impaired regeneration, and discusses emerging therapeutic strategies targeting this axis to promote neuroprotect...
Raju Poongodi, Tao-Hsiang Yang, Kuender D. Yang et al.· International Journal of Mol...· 0 citations
INTRODUCTION
Neurodegenerative Diseases (NDDs), including Alzheimer's Disease (AD), Parkinson's Disease (PD), Amyotrophic Lateral Sclerosis (ALS), Huntington's Disease (HD), and Multiple Sclerosis (MS), are increasingly associated with ferroptosis, a regulated irondependent form of cell death characterised by the exces...
Nainsi Kumari, Shruti Dwivedi, Satyam Yadav et al.· Current Neurovascular Resear...· 0 citations
Although available evidence supports an association between ferroptosis-related processes and AD pathobiology, no single marker is sufficient to establish ferroptosis in human AD tissue, which restricts the diagnostic and therapeutic interpretation of ferroptosis in AD.
Yelizaveta A. Marakhovskaya, A. Churov, Mikhail Arbatsky et al.· Brain Research· 0 citations
This review examines the molecular crosstalk between oxidative stress and ferroptosis in ischemia–reperfusion injury and summarizes key pharmacological and natural agents that target these pathways to achieve neuroprotection.
Wasim Akhtar, Mohd Muazzam Khan, Sanjay Kumar et al.· Journal of Molecular Histolo...· 0 citations
Major depressive disorder (MDD) is a heterogeneous psychiatric disorder involving oxidative stress, neuroinflammation, mitochondrial dysfunction, impaired neuroplasticity, and metabolic dysregulation. Ferroptosis, an iron-dependent form of regulated cell death driven by phospholipid peroxidation and antioxidant defense...
De-Yue Kong, Rui-Qi Duan, Xiang-Yu Wang et al.· Biochemistry and Biophysics...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.